PRIMARY STRUCTURE OF APO-B-100

被引:20
作者
YANG, CY [1 ]
GU, ZW [1 ]
YANG, ML [1 ]
GOTTO, AM [1 ]
机构
[1] METHODIST HOSP,HOUSTON,TX 77030
关键词
APO-B-100 PRIMARY STRUCTURE; SULFHYDRYL AND DISULFIDE GROUPS OF APO-B-100; FREE SULFHYDRYL OF APO-B ON LDL; DISULFIDE LINKAGE OF LP[A;
D O I
10.1016/0009-3084(94)90128-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein B-100 (apoB-100) is the major protein in low-density lipoprotein (LDL) and contains the ligand for binding LDL to its cell surface receptor. Lipoprotein [a] (Lp[a]) is a lipoprotein that consists of LDL and apolipoprotein [a] (apo[a]). The primary structure of apoB-100 has been determined by a combination of recombinant DNA and protein sequencing methods. Using high-performance liquid chromatographic techniques, we have identified sulfhydryl and disulfide groups of apoB-100 from LDL. Sixteen of the 25 cysteine residues in apoB-100 exist in disulfide form. AII 14 cysteine residues within the N terminal end of apoB-100 are linked in disulfide bridges. Using the fluorescent sulfhydryl probe, 5-iodoacetoamidofluoresceine, two free sulfhydryls of apoB-100 on LDL were identified at positions 3734 and 4190. Based on its differential susceptibility to trypsin, apoB-100 can be divided into five domains: domain 1 (residues 1-1000), largely trypsin-releasable]e (TR); domain 2(residues 1001-1700), alternating TR and trypsin non-releasable (TN); domain 3 (residues 1701-3070), largely TN; domain 4 (residues 3071-4100), mainly TR and mixed; and domain 5 (residues 4101-4536), almost exclusively TN. Based on our data, we propose that the structure of apoB-100 in LDL is probably an elongated form that wraps around the LDL particle, and that Cys(3734) of apoB-100 may be the cysteine residue linked to a cysteine of apo[a].
引用
收藏
页码:99 / 104
页数:6
相关论文
共 24 条
  • [1] ARMSTRONG VW, 1985, J LIPID RES, V26, P1314
  • [2] ATKINSON D, 1988, CIRCULATION S2, V78, P2
  • [3] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS
    BROWN, MS
    GOLDSTEIN, JL
    [J]. SCIENCE, 1986, 232 (4746) : 34 - 47
  • [4] DISTRIBUTION OF LIPID-BINDING REGIONS IN HUMAN APOLIPOPROTEIN B-100
    CHEN, GC
    HARDMAN, DA
    HAMILTON, RL
    MENDEL, CM
    SCHILLING, JW
    ZHU, S
    LAU, K
    WONG, JS
    KANE, JP
    [J]. BIOCHEMISTRY, 1989, 28 (06) : 2477 - 2484
  • [5] CHEN SH, 1986, J BIOL CHEM, V261, P2918
  • [6] DETERMINATION OF CYSTEINE ON LOW-DENSITY LIPOPROTEINS USING THE FLUORESCENT-PROBE, 5-IODOACETAMIDOFLUORESCEINE
    COLEMAN, RD
    KIM, TW
    GOTTO, AM
    YANG, CY
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1037 (01) : 129 - 132
  • [7] DAHLEN G, 1975, CLIN GENET, V8, P183
  • [8] GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582
  • [9] PREDISPOSITION TO ATHEROSCLEROSIS IN HEAD, HEART, AND LEGS - FRAMINGHAM STUDY
    GORDON, T
    KANNEL, WB
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 221 (07): : 661 - &
  • [10] PROPOSED MECHANISMS FOR BINDING OF APO(A) KRINGLE TYPE-9 TO APO-B-100 IN HUMAN LIPOPROTEIN(A)
    GUEVARA, J
    SPURLINO, J
    JAN, AY
    YANG, CY
    TULINSKY, A
    PRASAD, BVV
    GAUBATZ, JW
    MORRISETT, JD
    [J]. BIOPHYSICAL JOURNAL, 1993, 64 (03) : 686 - 700